BSEP activators, short for Bile Salt Export Pump activators, represent a class of chemical compounds that exert a specific influence on a vital component of the human liver's biliary excretion system. Bile Salt Export Pump (BSEP), also known as ABCB11, is a transmembrane protein primarily expressed in hepatocytes, where it plays a pivotal role in the secretion of bile salts into the bile canaliculi. This process is essential for the removal of waste products, toxins, and excess cholesterol from the body. Bile salts, synthesized in the liver from cholesterol, facilitate the digestion and absorption of dietary fats in the small intestine. They are secreted into the bile ducts and ultimately into the gallbladder, from where they are released into the small intestine when needed for fat digestion. BSEP acts as a transporter protein that pumps bile salts from hepatocytes into the bile canaliculi, thus maintaining the bile salt pool's homeostasis.
BSEP activators are chemical compounds specifically designed or identified to enhance the activity of the Bile Salt Export Pump. These activators typically modulate the function of the BSEP protein, either by directly interacting with it or by indirectly affecting its expression and activity. By enhancing BSEP's function, these compounds facilitate the efficient secretion of bile salts into the bile, ensuring the proper digestion and absorption of dietary fats and the elimination of waste products. This class of chemicals holds significant importance in understanding the mechanisms behind bile salt transport and liver physiology. Moreover, BSEP activators have applications in various fields such as pharmacology, toxicology, and hepatic physiology research, as they allow scientists to manipulate bile salt transport mechanisms for experimental purposes, ultimately advancing our knowledge of liver function and related metabolic processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifamycin SV monosodium salt | 14897-39-3 | sc-205839 sc-205839A | 1 g 5 g | $94.00 $307.00 | ||
Rifamycin SV monosodium salt also induces BSEP expression and is researched for its potential therapeutic properties aiding in liver disease. | ||||||
Oleanolic Acid | 508-02-1 | sc-205775 sc-205775A | 100 mg 500 mg | $86.00 $302.00 | 8 | |
Oleanolic acid has been investigated for its potential as a BSEP activator. | ||||||
Chenodeoxycholic acid, free acid | 474-25-9 | sc-278835 sc-278835A | 1 g 5 g | $28.00 $117.00 | ||
Chenodeoxycholic acid, free acid (CDCA) is a bile acid that can activate BSEP, and it is currently being researched to reduce the likelihood of certain liver disorders. | ||||||
Ursodeoxycholic acid | 128-13-2 | sc-204935 sc-204935A | 1 g 5 g | $52.00 $131.00 | 4 | |
Ursodeoxycholic acid (UDCA) is another bile acid that can promote BSEP activity. It is under research for prevention of some forms of cholestatic liver diseases. | ||||||
Tauroursodeoxycholic Acid, Sodium Salt | 14605-22-2 | sc-281165 | 1 g | $644.00 | 5 | |
Tauroursodeoxycholic Acid, Sodium Salt (TUDCA) is a bile acid derivative that has been investigated for its potential to activate BSEP and improve liver function. | ||||||